Loading...
Printed on 7/20/2026
For informational purposes only. This is not medical advice.
The Global Deterioration Scale (Reisberg GDS) is a broad staging framework for progressive cognitive decline, especially in Alzheimer-type trajectories. It classifies severity from stage 1 (no cognitive decline) to stage 7 (very severe decline) and is commonly used for clinical communication, prognosis framing, and care planning.
Formula: Stage-based classification from 1 to 7 (non-additive stage scale).
Save your results with a free account
Keep a history of calculations, favorite tools, and access your dashboard anytime.
The Global Deterioration Scale (GDS) by Reisberg et al. (1982) stages cognitive and functional decline through a clinician-administered global assessment. Unlike domain-specific tools (CDR, MMSE), GDS provides a holistic gestalt impression of dementia stage through a combination of: informant interview about observed cognitive and functional changes, direct patient cognitive observation and interview, and review of available clinical documentation. The clinician synthesizes all available information to assign the single best-fit GDS stage (1-7) that describes the patient's overall cognitive and functional status. No numerical score is computed — the output is a single stage assignment based on clinical judgment guided by the GDS anchor descriptions. The assessment typically requires 20-30 minutes, including informant interview.
The GDS provides detailed clinical anchor descriptions for each of seven stages. Stage 1 (Normal): No subjective or objective cognitive deficits. Stage 2 (Normal Aged Forgetfulness): Subjective memory complaints (forgetting names, locations of objects) but normal objective testing and social/occupational function. Stage 3 (Mild Cognitive Impairment): Objective evidence of mild impairment — gets lost in unfamiliar locations, word-finding difficulty, reduced occupational performance, mild social withdrawal; family aware of deficits; lasts average 7 years. Stage 4 (Mild Dementia): Clear deficits on clinical interview — decreased knowledge of recent events, impaired recall of personal history, difficulty with complex tasks (finances, travel planning), emotional blunting, denial; MMSE typically 19-26. Stage 5 (Moderate Dementia): Cannot recall major relevant aspects of current life (address, phone number, names of close relatives); requires assistance with ADLs; disoriented to time/place; MMSE typically 11-18. Stage 6 (Moderately Severe): Requires extensive assistance — occasionally forgets spouse's name, unaware of recent events, largely unaware of surroundings; incontinence develops; personality changes; MMSE typically 3-10. Stage 7 (Severe/Late): All verbal abilities lost; basic psychomotor activities lost; rigidity, incontinence throughout.
GDS staging guides clinical decisions and caregiver communication: GDS 2 = Monitor, address anxiety about memory, reassure if no objective impairment. GDS 3 = Comprehensive evaluation, biomarker assessment if available, driving assessment, advance directive discussion. GDS 4 = Cholinesterase inhibitor initiation (if Alzheimer's disease), driving cessation, financial management support, safety planning. GDS 5 = Intensive home care or residential care consideration, continence management, medication management by caregiver. GDS 6 = Memory care unit or nursing home, behavioral management for BPSD, comfort-focused goals integration. GDS 7 = Full comfort care, hospice eligibility assessment, dysphagia management, pressure injury prevention, family bereavement support. GDS stage is used to calibrate caregiver expectations and plan for upcoming care milestones.
Geriatricians, memory clinic nurses, social workers, dementia care coordinators
GDS provides a highly intuitive framework for communicating dementia trajectory to families and caregivers. The seven-stage description language ('at GDS 5, your mother will know you but may not recall her home address') is more accessible than MMSE scores or CDR ratings. When used in caregiver education sessions, GDS staging helps families understand what behavioral changes to expect at each stage and what care interventions are appropriate. GDS-based anticipatory guidance reduces caregiver crisis calls, improves preparation for care level transitions, and supports advance care planning conversations.
Geriatricians, neurologists, geriatric psychiatrists, memory clinic teams
GDS provides a quick holistic staging framework for initial dementia evaluation visits in memory clinics. The GDS can be assigned based on the clinical interview and informant history without additional formal testing — making it valuable when patients are fatigued or testing is limited by time. GDS staging is complementary to CDR (which requires more structured assessment) and MMSE (which measures cognitive performance). GDS at initial evaluation documents the baseline severity level for longitudinal tracking. GDS stages 3-4 at initial memory clinic presentation indicate the most prevalent referral presentations for workup.
Palliative care teams, hospice physicians, nursing home medical directors
GDS stage 7 characterizes the most advanced dementia phase and informs hospice eligibility discussions alongside FAST staging. GDS 7 sub-stages (7a-7e) describe increasing severity within the terminal phase: 7a = speech up to 5-6 words (corresponds to FAST 7a), through 7e = holds up head (corresponding to FAST 7f). GDS 7 with concurrent serious medical illness supports hospice referral and advance care planning conversations focused on comfort-focused goals. At GDS 6-7, preventive medications (statins, aspirin, bisphosphonates) are typically discontinued as burden outweighs benefit.
Nursing home physicians, nursing home administrators, care planning teams
GDS staging informs nursing home level of care and resource planning. GDS 4-5 patients typically benefit from enhanced memory care programs with structured activities and increased supervision. GDS 6 patients require memory care units with wandering prevention, incontinence management, and behavioral BPSD protocols. GDS 7 patients require specialized late-stage dementia care with comfort-focused goals, dysphagia management, and pressure injury prevention. GDS staging in nursing home admission assessment documents baseline severity for MDS 3.0, BIMS, and FAST correlation.
Geriatric psychiatrists, behavior management teams, consultation-liaison psychiatrists
GDS stage informs the expected behavioral and psychological symptoms of dementia (BPSD) trajectory. GDS 4-5 patients more commonly exhibit depression, anxiety, and irritability — requiring mood management. GDS 6 patients more commonly exhibit agitation, aggression, psychosis, and sleep disturbance — requiring behavioral intervention and carefully considered pharmacotherapy. GDS 7 patients may exhibit motor behaviors, vocalization, and food refusal. GDS-stage-specific BPSD profiles help geriatric psychiatry teams prioritize their assessment and intervention approach.
Activity therapists, occupational therapists, recreational therapists
GDS staging guides the appropriate level and type of activity programming for dementia residents. GDS 3-4: complex cognitive activities (word games, reading, computer activities), group discussions, hobby continuation. GDS 5: structured simple activities (sorting tasks, simple crafts), reality orientation exercises, familiar music. GDS 6: sensory stimulation (music therapy, tactile activities, gardening), repetitive simple tasks, caregiver-mediated interaction. GDS 7: passive sensory stimulation (music, touch, aromatherapy), comfort-focused engagement, family involvement programs. Activity therapists document GDS stage in assessment forms to align programming with cognitive capacity.
GDS staging requires integrating the entire clinical picture: informant history, direct patient observation, functional status, and available test results. Resist the temptation to assign GDS stage based solely on MMSE score — MMSE-GDS concordance is approximate and individual patients can have MMSE-GDS discordance (high premorbid intelligence may preserve MMSE despite significant functional decline). The GDS anchor descriptions, not MMSE scores, are the primary basis for stage assignment.
A GDS stage assignment without supporting documentation is clinically unhelpful. Document: 'Patient at GDS stage 5 — cannot reliably recall home address or phone number, requires clothing selection assistance, disoriented to year and month, community activity participation reduced to supervised outings only.' This specific documentation protects the GDS assignment against challenge, informs care team members unfamiliar with the patient, and provides the detailed baseline needed for meaningful serial comparison.
GDS 2 is a normal variant — subjective memory complaints without objective impairment or functional deficit. The critical distinction from GDS 3 (MCI) is: Does the patient have objective evidence of impairment on clinical testing? Does the patient have difficulty with complex tasks (finances, navigation, work performance) beyond normal aging? Is the impairment recognized by others who know the patient well? GDS 2 patients can be reassured with monitoring. GDS 3 patients require comprehensive evaluation, follow-up, and increasingly biomarker assessment.
The GDS anchor descriptions are written in family-accessible language that supports realistic expectation setting. When a GDS 5 patient's family insists 'she just needs reminders' and resists intensive care planning, reviewing the GDS 5 anchor description ('cannot recall home address or phone number, requires assistance with dressing') with the family aligns expectations with clinical reality. GDS-based psychoeducation is more effective than abstract statistics about dementia trajectory.
GDS progression from stage 4 to stage 5 over 18 months indicates rapid progression; stable GDS 4 over 3 years indicates slow progression. Document GDS stage and date at each assessment. Rapid GDS progression (advancing 1 full stage per year) triggers care urgency: earlier residential care planning, earlier advance directive completion, earlier family support activation. Slow progression allows a longer window for maintaining independence and quality of life with modest support.
GDS was developed for Alzheimer's disease and its retrogenesis framework. For other dementias: Vascular dementia may show a more stepwise rather than gradual progression pattern, making GDS stage assignment at any single time point less predictive of future trajectory. FTD may show disproportionate behavioral and language changes at GDS 3-4 with relatively preserved memory — note this discordance. Lewy Body dementia fluctuations may cause apparent day-to-day GDS variation. Apply GDS with explicit acknowledgment of dementia subtype when it differs from Alzheimer's disease.
Reisberg GDS is a long-standing dementia progression framework used in both research and clinical care for stage communication.
Higher GDS stages indicate greater severity of cognitive decline and higher caregiving/support needs.
Use in dementia evaluation and follow-up to standardize severity communication, prognosis context, and care-level planning.
GDS reflects generalized progression patterns and may be less precise in non-Alzheimer or mixed etiologies without complementary assessment.
Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.
April 21, 2026 · trust-baseline
Clinical trust metadata enabled for this tool page with structured review/version fields.
Classify dementia severity with the Clinical Dementia Rating global stage (0, 0.5, 1, 2, 3).
OpenGeriatricsClassify functional dementia progression using FAST stages 1 through 7f.
OpenGeriatricsClassify SLUMS cognitive-screen totals (0-30) to support triage for fuller neurocognitive evaluation.
OpenMental HealthInterpret Montreal Cognitive Assessment (MoCA) scores. The leading cognitive screening tool for mild cognitive impairment and dementia.
Open